Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 38

1.

Retraction: Inhibition of RelA phosphorylation sensitizes chemotherapeutic agents-mediated apoptosis in constitutive NF-kappaB-expressing and chemoresistant cells.

[No authors listed]

Cell Death Differ. 2013 May;20(5):784. doi: 10.1038/cdd.2013.18. Epub 2013 Mar 1. No abstract available.

2.

Inhibition of RelA phosphorylation sensitizes apoptosis in constitutive NF-kappaB-expressing and chemoresistant cells.

Manna SK, Manna P, Sarkar A.

Cell Death Differ. 2007 Jan;14(1):158-70. Epub 2006 Apr 28. Erratum in: Cell Death Differ. 2012 Sep;19(9):1572. Retraction in: Cell Death Differ. 2013 May;20(5):784.

3.

Role of Rel/NF-kappaB transcription factors in apoptosis of human hepatocellular carcinoma cells.

Chiao PJ, Na R, Niu J, Sclabas GM, Dong Q, Curley SA.

Cancer. 2002 Oct 15;95(8):1696-705.

4.

Decrease in RelA phosphorylation by inhibiting protein kinase A induces cell death in NF-kappaB-expressing and drug-resistant tumor cells.

Manna SK, Gangadharan C.

Mol Immunol. 2009 Apr;46(7):1340-50. doi: 10.1016/j.molimm.2008.11.014. Epub 2009 Jan 6.

PMID:
19128834
5.

Inhibition of NF-kappaB activity by BAY 11-7082 increases apoptosis in multidrug resistant leukemic T-cell lines.

García MG, Alaniz L, Lopes EC, Blanco G, Hajos SE, Alvarez E.

Leuk Res. 2005 Dec;29(12):1425-34. Epub 2005 Jun 27.

PMID:
15982733
7.

Combined histone deacetylase and NF-kappaB inhibition sensitizes non-small cell lung cancer to cell death.

Rundall BK, Denlinger CE, Jones DR.

Surgery. 2004 Aug;136(2):416-25.

PMID:
15300209
9.

Inactivation of NF-kappaB by 3,3'-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells.

Rahman KM, Ali S, Aboukameel A, Sarkar SH, Wang Z, Philip PA, Sakr WA, Raz A.

Mol Cancer Ther. 2007 Oct;6(10):2757-65. Epub 2007 Oct 3.

10.

Pim-1 controls NF-kappaB signalling by stabilizing RelA/p65.

Nihira K, Ando Y, Yamaguchi T, Kagami Y, Miki Y, Yoshida K.

Cell Death Differ. 2010 Apr;17(4):689-98. doi: 10.1038/cdd.2009.174. Epub 2009 Nov 13.

12.

The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis.

Dong QG, Sclabas GM, Fujioka S, Schmidt C, Peng B, Wu T, Tsao MS, Evans DB, Abbruzzese JL, McDonnell TJ, Chiao PJ.

Oncogene. 2002 Sep 19;21(42):6510-9.

13.

Cisplatin mimics ARF tumor suppressor regulation of RelA (p65) nuclear factor-kappaB transactivation.

Campbell KJ, Witty JM, Rocha S, Perkins ND.

Cancer Res. 2006 Jan 15;66(2):929-35.

14.

Inhibition of NF-kappaB sensitizes non-small cell lung cancer cells to chemotherapy-induced apoptosis.

Jones DR, Broad RM, Madrid LV, Baldwin AS Jr, Mayo MW.

Ann Thorac Surg. 2000 Sep;70(3):930-6; discussion 936-7.

PMID:
11016336
16.

ATM mediates constitutive NF-kappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia.

Grosjean-Raillard J, Tailler M, Adès L, Perfettini JL, Fabre C, Braun T, De Botton S, Fenaux P, Kroemer G.

Oncogene. 2009 Feb 26;28(8):1099-109. doi: 10.1038/onc.2008.457. Epub 2008 Dec 15.

PMID:
19079347
17.
18.
19.

Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth.

Nakshatri H, Bhat-Nakshatri P, Martin DA, Goulet RJ Jr, Sledge GW Jr.

Mol Cell Biol. 1997 Jul;17(7):3629-39.

20.

The role of p65 NF-kappaB/RelA in pancreatitis-induced Kupffer cell apoptosis.

Peng Y, Gallagher SF, Landmann R, Haines K, Murr MM.

J Gastrointest Surg. 2006 Jun;10(6):837-47.

PMID:
16769540

Supplemental Content

Support Center